Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Josy Breuer"'
Autor:
Colin G Miller, Liz Kuney, Michael O’Connor, Richard C. Walovitch, Annette Schmid, Robert W. Ford, Josy Breuer, Robert Ford, Guenther Brueggenwerth, David L. Raunig
Publikováno v:
Therapeutic Innovation & Regulatory Science
The debate over human visual perception and how medical images should be interpreted have persisted since X-rays were the only imaging technique available. Concerns over rates of disagreement between expert image readers are associated with much of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6681f8527778526cd59b6e3491cda7a
https://doi.org/10.1007/s43441-021-00316-6
https://doi.org/10.1007/s43441-021-00316-6
Publikováno v:
Acta Radiologica (Stockholm, Sweden : 1987)
Background Safety data on routine clinical use of gadoxetate disodium in elderly patients is not reported yet. Purpose To assess the safety of liver specific gadoxetate disodium in contrast enhanced magnetic resonance imaging in elderly patients (≥
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28348092b6a3b8f82e0ccbc3829f2d24
https://doi.org/10.1177/0284185117700673
https://doi.org/10.1177/0284185117700673
Publikováno v:
Investigative Radiology. 51:537-543
ObjectiveThe aim of this study was to provide a systematic safety analysis of gadobutrol after more than 29 million applications in clinical routine.Materials and MethodsForty-two clinical development phase II to IV studies on gadobutrol or comparato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac33f96fd6013588f6710ac53ec5dec
https://doi.org/10.1097/rli.0000000000000270
https://doi.org/10.1097/rli.0000000000000270
Publikováno v:
Acta Radiologica (Stockholm, Sweden : 1987)
Background Safety data on routine clinical use of gadoxetate disodium for liver magnetic resonance imaging (MRI) is not reported yet. Purpose To assess the safety profile of gadoxetate disodium for liver MRI in the routine clinical setting. Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c73f348b6ce8aaa2d1f1c43e683dba
https://doi.org/10.1177/0284185115588126
https://doi.org/10.1177/0284185115588126
Publikováno v:
Magnetic Resonance in Medical Sciences
Purpose: Gadobutrol 1.0 M is macrocyclic gadolinium-based contrast agent for magnetic resonance imaging (MRI). This multicenter, open-label, phase 3 study aimed to investigate the efficacy and safety of gadobutrol-enhanced versus unenhanced MRI in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f4b145fa918f9aa327bb03d52501af
http://europepmc.org/articles/PMC5600060
http://europepmc.org/articles/PMC5600060
Autor:
Yi Huan, Mitsuhiro Tozaki, Weiwu Yao, Josy Breuer, Satoru Takahashi, Shuichiro Kaji, Tokugen Ro, Hiroshi Nishimura, Yoshifumi Sugawara, Lin Ma, Gaojun Teng, Byung Chul Kang, Masahiro Endo, Ryo Sugihara, Yasuko Aitoku, Shigeaki Umeoka, Seong Tae Hahn, Ryohei Kuwatsuru, Nobuyuki Katakami, Weijun Peng, Liang Guo, Mengsu Zeng
Publikováno v:
Journal of Magnetic Resonance Imaging. 41:404-413
Purpose To demonstrate the noninferiority of gadobutrol-enhanced magnetic resonance imaging (MRI) compared with gadopentetate dimeglumine-enhanced MRI in Asian patients referred for contrast-enhanced imaging of the body or extremities. Materials and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f33322c0789bd00e08b3d034a71500
https://doi.org/10.1002/jmri.24566
https://doi.org/10.1002/jmri.24566
Publikováno v:
Journal of Magnetic Resonance Imaging. 39:410-418
Purpose To investigate the efficacy and safety of three doses of gadobutrol and determine the minimum effective dose for contrast-enhanced MRI of the central nervous system (CNS). Materials and Methods This was a Phase II, multicenter, double-blind,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e96ae789dabb4a9d02019f30ba258f70
https://doi.org/10.1002/jmri.24180
https://doi.org/10.1002/jmri.24180
Autor:
Zonghui Liang, Lin Ma, Dehang Wang, Yi Huan, Ping Li, Jun Yu, Zhenwei Yao, Shuang Chen, Huijin He, Xiaoyuan Feng, Josy Breuer
Publikováno v:
Magnetic Resonance Insights, Vol 2012, Iss 5, Pp 17-28 (2012)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::006572ce36a9c32f14c82cd85101f45d
http://la-press.com/efficacy-and-safety-of-gadobutrol-10-m-versus-gadopentetate-dimeglumin-a3357
http://la-press.com/efficacy-and-safety-of-gadobutrol-10-m-versus-gadopentetate-dimeglumin-a3357
Publikováno v:
Imaging in Medicine. 4:25-40
Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e68b0910483b9fa80cf5ef887b8ff68
https://doi.org/10.2217/iim.11.70
https://doi.org/10.2217/iim.11.70
Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment
Publikováno v:
Investigative Radiology. 46:556-566
The purpose of this study was to determine the pharmacokinetics (PKs), imaging properties, and safety of the liver-specific magnetic resonance (MR) imaging contrast agent gadoxetic acid disodium (Gd-EOB-DTPA) in subjects with various levels of hepati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368bbd68348ae3d57f97d3503f18d95d
https://doi.org/10.1097/rli.0b013e31821a218a
https://doi.org/10.1097/rli.0b013e31821a218a